DEXCOM INC (1DXCM.MI) Stock Price & Overview
BIT:1DXCM • US2521311074
Current stock price
The current stock price of 1DXCM.MI is 62.77 EUR. Today 1DXCM.MI is up by 2.58%.
1DXCM.MI Key Statistics
- Market Cap
- 24.158B
- P/E
- 34.68
- Fwd P/E
- 28.71
- EPS (TTM)
- 1.81
- Dividend Yield
- N/A
1DXCM.MI Stock Performance
1DXCM.MI Stock Chart
1DXCM.MI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to 1DXCM.MI.
1DXCM.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 1DXCM.MI. 1DXCM.MI gets an excellent profitability rating and is at the same time showing great financial health properties.
1DXCM.MI Earnings
On February 12, 2026 1DXCM.MI reported an EPS of 0.45 and a revenue of 1.26B. The company missed EPS expectations (-32.12% surprise) and missed revenue expectations (-0.9% surprise).
1DXCM.MI Forecast & Estimates
37 analysts have analysed 1DXCM.MI and the average price target is 74.94 EUR. This implies a price increase of 19.39% is expected in the next year compared to the current price of 62.77.
For the next year, analysts expect an EPS growth of 20.81% and a revenue growth 12.81% for 1DXCM.MI
1DXCM.MI Groups
Sector & Classification
1DXCM.MI Financial Highlights
Over the last trailing twelve months 1DXCM.MI reported a non-GAAP Earnings per Share(EPS) of 1.81. The EPS increased by 26.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 15.96% | ||
| ROA | 9.61% | ||
| ROE | 26.44% | ||
| Debt/Equity | 0.47 |
1DXCM.MI Ownership
1DXCM.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 14.51 | 100.151B | ||
| 2M6 | MEDTRONIC PLC | 14.15 | 97.113B | ||
| SHL | SIEMENS HEALTHINEERS AG | 14.01 | 41.725B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 16.04 | 23.621B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 15.15 | 22.311B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 14.93 | 22.302B | ||
| BIM | BIOMERIEUX | 18.6 | 10.96B | ||
| DIA | DIASORIN SPA | 15.57 | 3.56B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 15.37 | 3.292B | ||
| 1AFX | CARL ZEISS MEDITEC AG - BR | 10.14 | 2.139B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.46 | 2.109B | ||
| DRW3 | DRAEGERWERK AG - PREF | 10.77 | 1.632B | ||
| DRW8 | DRAEGERWERK AG | 8.62 | 1.291B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1DXCM.MI
Company Profile
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. The company is headquartered in San Diego, California and currently employs 11,000 full-time employees. The company went IPO on 2005-04-14. The firm is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The firm enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
Company Info
IPO: 2005-04-14
DEXCOM INC
6340 Sequence Drive
San Diego CALIFORNIA US
Employees: 11000
Phone: 13026365400
DEXCOM INC / 1DXCM.MI FAQ
Can you describe the business of DEXCOM INC?
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. The company is headquartered in San Diego, California and currently employs 11,000 full-time employees. The company went IPO on 2005-04-14. The firm is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The firm enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
Can you provide the latest stock price for DEXCOM INC?
The current stock price of 1DXCM.MI is 62.77 EUR. The price increased by 2.58% in the last trading session.
Does 1DXCM stock pay dividends?
1DXCM.MI does not pay a dividend.
What is the ChartMill technical and fundamental rating of 1DXCM stock?
1DXCM.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the valuation of DEXCOM INC (1DXCM.MI) based on its PE ratio?
The PE ratio for DEXCOM INC (1DXCM.MI) is 34.68. This is based on the reported non-GAAP earnings per share of 1.81 and the current share price of 62.77 EUR.
What is the employee count for 1DXCM stock?
DEXCOM INC (1DXCM.MI) currently has 11000 employees.
Who owns DEXCOM INC?
You can find the ownership structure of DEXCOM INC (1DXCM.MI) on the Ownership tab.